← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 1, 2010Last known activity
Oct 1, 2010
Acquired by Eyepoint Pharmaceuticals on Mar 28, 2018
Timeline
2000s
- Jun 1, 2004
Icon Bioscience— Founded
2010s
- Mar 28, 2018
Eyepoint Pharmaceuticals— Acquired By
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (1)
- NCT01214174Overall official - principal investigatorPhase 2Oct 1, 2010
Details
- Founded
- Sunnyvale, CA, US Jun 1, 2004
- Last known activity
- Oct 1, 2010